English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

carnitine/neoplasms

The link is saved to the clipboard
Page 1 from 16 results

Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION Fatty acids are catabolized, mostly, in the mitochondria through the .beta.-oxidation pathway, where the carnitine palmitoyltransferase (CPT) system plays a key role in transporting long chain fatty acids (FAs) from the cytoplasm to the mitochondrial matrix. The CPT

Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate

Only registered users can translate articles
Log In/Sign up
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Treatment of cancers

Only registered users can translate articles
Log In/Sign up
The present invention relates to the treatment of cancers using aplidine or related compounds which are aplidine analogs. BACKGROUND OF INVENTION Cancer comprises a group of malignant neoplasms that can be divided into two categories, carcinoma, comprising a majority of the cases observed in the

Method of using .beta.-hydroxy-.beta.-methylbutyrate for the treatment of disease conditions

Only registered users can translate articles
Log In/Sign up
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate for treating disease-associated wasting

Only registered users can translate articles
Log In/Sign up
BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

HMB uses thereof

Only registered users can translate articles
Log In/Sign up
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5

Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting

Only registered users can translate articles
Log In/Sign up
BACKGROUND Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall

Nutrient compositions and methods for enhanced effectiveness of the immune system

Only registered users can translate articles
Log In/Sign up
This invention relates generally to promoting the healing process of physiological disorders or diseases and, more specifically to nutrient compositions that promote the effectiveness or efficiency of the immune system. Physiological disorders and diseases affect millions of individuals each year.

Nutrient compositions and methods for enhanced effectiveness of the immune system

Only registered users can translate articles
Log In/Sign up
This invention relates generally to promoting the healing process of physiological disorders or diseases and, more specifically to nutrient compositions that promote the effectiveness or efficiency of the immune system. Physiological disorders and diseases affect millions of individuals each year.

Multivitamin-mineral regimens for longevity and wellness

Only registered users can translate articles
Log In/Sign up
CROSS REFERENCE This application claims priority to U.S. patent application Ser. No. 13/043,056 filed Mar. 8, 2011 and U.S. patent application Ser. No. 13/043,216 filed Mar. 8, 2011, the specifications of which are incorporated herein by reference in their entirety. BACKGROUND OF THE INVENTION The

Multivitamin-mineral regimens for longevity and wellness

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention features novel dietary supplements, which may benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, dementia/Alzheimer's disease, high blood pressure, high cholesterol, coronary

Multivitamin-mineral regimens for longevity and wellness

Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION The present invention features novel dietary supplements, which may benefit individuals suffering from various conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, dementia/Alzheimer's disease, high blood pressure, high cholesterol, coronary

Enteral nutritional product

Only registered users can translate articles
Log In/Sign up
The present invention relates to an enteral nutritional supplement for persons with cancer who are not currently undergoing radiation therapy and/or chemotherapy. Cancer patients typically undergo intermittent periods of chemotherapy and/or radiation therapy during which their nutritional needs are

Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to a method for increasing the intestinal absorption, cellular concentration, biliary secretion, hepatic storage, and/or liver concentration of a fat soluble vitamin in a post-menopausal woman or a lower animal by orally administering L-carnitine and a

Method of producing therapeutic agent

Only registered users can translate articles
Log In/Sign up
BACKGROUND 1. Technical Field of the Invention The present invention relates to a method of producing a therapeutic agent for use in the prevention of cancer that arises from mutations to the BRCA1 and BRCA2 genes, i.e., breast and ovarian, and the treatment of several types of human diseases
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge